OSI Pharmaceuticals' IPO

OSI Pharmaceuticals raised a round of funding on November 12, 2004. Investors include Public.

OSI Pharmaceuticals is a biotechnology company primarily focused on the discovery, development, and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes, an…

Articles about OSI Pharmaceuticals' IPO: